Trial Profile
The medicinal efficacy of Elobixibat in chronic constipation with type 2 diabetes mellitus
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Elobixibat (Primary) ; Lubiprostone
- Indications Constipation
- Focus Therapeutic Use
- 13 Oct 2019 Status changed from not yet recruiting to recruiting.
- 30 Nov 2018 New trial record